Nav: Home

Research improves understanding of mechanism of atrial fibrillation

October 21, 2019

Atrial fibrillation is the most common heart arrhythmia in humans. This condition increases the risk of heart failure, stroke, dementia and death, and current treatments have suboptimal efficacy and carry side effects. Looking to identify clues that might lead to better treatments, a group headed by researchers at Baylor College of Medicine and the Texas Heart Institute used a mouse model system to investigate how noncoding DNA regions that increase atrial fibrillation risk in humans work to predispose to the condition.

The team reports in the Proceedings of the National Academy of Sciences a functional connection between noncoding DNA regions called Pitx2 enhancers, expression of the Pitx2 gene and atrial fibrillation. The researchers found that distant Pitx2 enhancers loop and fold to make contact with the Pitx2 gene, and this interaction prevents predisposition to atrial fibrillation.

"Atrial fibrillation occurs when the two upper chambers of the heart, the atria, are beating out of sync with the two lower chambers, the ventricles. The uncoordinated beats prevent the heart from pumping effectively and thus increase the risk of heart failure, dementia, stroke and death," said corresponding author Dr. James F. Martin, professor and Vivian L. Smith Chair in Regenerative Medicine at Baylor and director of the Cardiomyocyte Renewal Lab at the Texas Heart Institute.

There is an unmet need for effective treatments for atrial fibrillation, and one approach to identify potential therapeutic strategies is to conduct genome-wide association studies (GWAS) to identify genes that are involved in this condition. GWAS identify molecular alterations across the entire genome; that is, on both protein-coding genes and on their noncoding regulatory regions.

Previous GWAS studies implicated the Pitx2 gene - a gene that produces a protein involved in mammalian development - as the most commonly found gene in the human genome that was associated with atrial fibrillation. GWAS studies also have determined that a noncoding DNA region located near the Pitx2 gene is well associated with increased risk for atrial fibrillation. However, a connection between the Pitx2 gene and the noncoding region has not been shown.

In the current study, Martin and his colleagues developed a mouse model to investigate whether the noncoding DNA region was functionally linked to the Pitx2 gene.

"We know that the DNA's linear structure can loop and fold and this enables regions that are sequentially far away from each other to make contact," Martin said. "Here we showed that noncoding DNA regions associated with predisposition to atrial fibrillation loop to the Pitx2 gene. Furthermore, deleting the noncoding DNA regions, called Pitx2 enhancers, resulted in decreased Pitx2 gene expression and predisposed mice to atrial fibrillation."

"In summary, noncoding DNA regions linked to atrial fibrillation risk can display long-range regulatory functions directed at Pitx2 gene and in this way predispose to the condition," Martin said.

Interestingly, deleting Pitx2 enhancers decreased Pitx2 gene expression and raised the risk for atrial fibrillation only in males. The Martin lab is interested in investigating the reasons behind this gender difference.
-end-
Other contributors to this work include Min Zhang, Matthew C. Hill, Zachary A. Kadow, Ji Ho Suh, Nathan R. Tucker, Amelia W. Hall, Tien T. Tran, Paul S. Swinton, John P. Leach, Kenneth B. Margulies, Patrick T. Ellinor and Na Li. The authors are associated with one or more of the following institutions: Baylor College of Medicine, Shanghai Jiao Tong University School of Medicine, Massachusetts General Hospital, the Broad Institute of MIT and Harvard, Texas Heart Institute and University of Pennsylvania Perelman School of Medicine.

This work was supported by National Institutes of Health Grants DE023177, HL127717, HL130804, HL118761, F31HL136065 and HL140187. Further support was provided by the Vivian L. Smith Foundation, Fondation LeDucq Transatlantic Networks of Excellence in Cardiovascular Research Grant 14CVD01, Chinese Postdoctoral Science Foundation Grant 2016M601610, Intellectual and Developmental Disabilities Research Center Grant 1U54 HD083092, the Eunice Kennedy Shriver National Institute of Child Health and Human Development and Mouse Phenotyping Core Grant U54 HG006348.

Baylor College of Medicine

Related Heart Failure Articles:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication
Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.
Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.
Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population
Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.
Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.
Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.
Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.
How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.
Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
More Heart Failure News and Heart Failure Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Debbie Millman: Designing Our Lives
From prehistoric cave art to today's social media feeds, to design is to be human. This hour, designer Debbie Millman guides us through a world made and remade–and helps us design our own paths.
Now Playing: Science for the People

#574 State of the Heart
This week we focus on heart disease, heart failure, what blood pressure is and why it's bad when it's high. Host Rachelle Saunders talks with physician, clinical researcher, and writer Haider Warraich about his book "State of the Heart: Exploring the History, Science, and Future of Cardiac Disease" and the ails of our hearts.
Now Playing: Radiolab

Insomnia Line
Coronasomnia is a not-so-surprising side-effect of the global pandemic. More and more of us are having trouble falling asleep. We wanted to find a way to get inside that nighttime world, to see why people are awake and what they are thinking about. So what'd Radiolab decide to do?  Open up the phone lines and talk to you. We created an insomnia hotline and on this week's experimental episode, we stayed up all night, taking hundreds of calls, spilling secrets, and at long last, watching the sunrise peek through.   This episode was produced by Lulu Miller with Rachael Cusick, Tracie Hunte, Tobin Low, Sarah Qari, Molly Webster, Pat Walters, Shima Oliaee, and Jonny Moens. Want more Radiolab in your life? Sign up for our newsletter! We share our latest favorites: articles, tv shows, funny Youtube videos, chocolate chip cookie recipes, and more. Support Radiolab by becoming a member today at Radiolab.org/donate.